Related Experiment Video

Updated: Jun 21, 2025

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry
11:32

Determination of the Relative Cell Surface and Total Expression of Recombinant Ion Channels Using Flow Cytometry

Published on: September 28, 2016

13.3K

[Cardiac channelopathies in the context of hereditary arrhythmia syndromes]

Moritz T Huttelmaier1, Thomas H Fischer2

  • 1Medizinische Klinik 1, Universitätsklinikum Würzburg, Oberdürrbacher Str. 6, 97080, Würzburg, Deutschland.

Innere Medizin (Heidelberg, Germany)
|July 8, 2024
PubMed

Insights

Genetic arrhythmia disorders, like long/short QT syndrome and Brugada syndrome, are rare but cause sudden cardiac death. Early diagnosis and treatment significantly improve patient outcomes and quality of life.

Area of Science:

  • Cardiology
  • Genetics
  • Rare Diseases

Background:

  • Genetic arrhythmia disorders are a significant cause of sudden cardiac death in young individuals.
  • These disorders are broadly classified into channelopathies and cardiomyopathies.
  • This paper specifically addresses key channelopathies: long QT syndrome, short QT syndrome, Brugada syndrome, and CPVT.

Purpose of the Study:

  • To elucidate the pathophysiological and genetic underpinnings of specific genetic arrhythmia channelopathies.
  • To detail the clinical presentations of these conditions.
  • To outline diagnostic, risk stratification, and therapeutic strategies for affected patients.

Main Methods:

  • Review of existing literature on genetic arrhythmia channelopathies.
  • Analysis of pathophysiological mechanisms and genetic bases.
  • Synthesis of clinical manifestations, diagnostic criteria, and treatment guidelines.

Main Results:

  • Genetic channelopathies, including long/short QT syndrome, Brugada syndrome, and CPVT, share common genetic and pathophysiological pathways.
  • Distinct clinical manifestations aid in diagnosis.
  • Early identification is crucial for effective management.

Conclusions:

  • Genetic arrhythmia channelopathies necessitate prompt diagnosis for improved prognosis.
  • A multi-faceted approach involving drug therapy, behavioral modifications, and device implantation (if needed) enhances patient quality of life.
  • Understanding the genetic basis is key to targeted diagnosis and therapy.

Keywords:
Brugada syndromeCatecholaminergic polymorphic ventricular tachycardiaLong QT syndromeShort QT syndromeSudden cardiac death

More Related Videos

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia09:36

Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia

Published on: December 22, 2023

1.2K
Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes11:33

Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes

Published on: March 12, 2013

13.4K

Related Concept Videos

Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
909
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
932
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.3K
Electrophysiology of Normal Cardiac Rhythm01:19

Electrophysiology of Normal Cardiac Rhythm

The normal cardiac rhythm is a synchronized electrical activity that facilitates the regular and coordinated contraction of the heart muscle. This process is essential for efficient blood circulation throughout the body. The fundamental elements involved in establishing and maintaining this rhythm include the unique electrical properties of cardiac muscle cells, the sinoatrial (SA) node's pacemaker function, the specialized conducting system, and the ionic mechanisms underlying each phase...
3.0K
ECG Interpretation of Arrhythmias I: Sinus Arrhythmias01:16

ECG Interpretation of Arrhythmias I: Sinus Arrhythmias

Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
208
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of...
964